These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31217300)

  • 21. The Vacuolar Ca
    Luna-Tapia A; DeJarnette C; Sansevere E; Reitler P; Butts A; Hevener KE; Palmer GE
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30728284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenicity of Candida albicans: quest for a molecular switch.
    Datta A
    Braz J Med Biol Res; 1994 Dec; 27(12):2721-32. PubMed ID: 7549996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of Upc2p-Inducible
    Luna-Tapia A; Willems HME; Parker JE; Tournu H; Barker KS; Nishimoto AT; Rogers PD; Kelly SL; Peters BM; Palmer GE
    mBio; 2018 May; 9(3):. PubMed ID: 29789366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Host-pathogen interactions and the pathological consequences of acute systemic Candida albicans infections in mice.
    Rozell B; Ljungdahl PO; Martínez P
    Curr Drug Targets; 2006 Apr; 7(4):483-94. PubMed ID: 16611036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virulence of Candida albicans mutants.
    Polak A
    Mycoses; 1992; 35(1-2):9-16. PubMed ID: 1406791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virulence and hyphal formation of Candida albicans require the Ste20p-like protein kinase CaCla4p.
    Leberer E; Ziegelbauer K; Schmidt A; Harcus D; Dignard D; Ash J; Johnson L; Thomas DY
    Curr Biol; 1997 Aug; 7(8):539-46. PubMed ID: 9259554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KRE5 gene null mutant strains of Candida albicans are avirulent and have altered cell wall composition and hypha formation properties.
    Herrero AB; Magnelli P; Mansour MK; Levitz SM; Bussey H; Abeijon C
    Eukaryot Cell; 2004 Dec; 3(6):1423-32. PubMed ID: 15590817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selection and pathogenicity of Candida albicans in HIV infection.
    Sweet SP
    Oral Dis; 1997 May; 3 Suppl 1():S88-95. PubMed ID: 9456665
    [No Abstract]   [Full Text] [Related]  

  • 29. Candida albicans Cannot Acquire Sufficient Ethanolamine from the Host To Support Virulence in the Absence of
    Davis SE; Tams RN; Solis NV; Wagner AS; Chen T; Jackson JW; Hasim S; Montedonico AE; Dinsmore J; Sparer TE; Filler SG; Reynolds TB
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29866908
    [No Abstract]   [Full Text] [Related]  

  • 30. High-frequency phenotypic switching in Candida albicans.
    Soll DR; Morrow B; Srikantha T
    Trends Genet; 1993 Feb; 9(2):61-5. PubMed ID: 8456504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Candida albicans regulator of disseminated infection operates primarily as a repressor and governs cell surface remodeling.
    Böhm L; Muralidhara P; Pérez JC
    Mol Microbiol; 2016 Apr; 100(2):328-44. PubMed ID: 26700268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strains and strategies for large-scale gene deletion studies of the diploid human fungal pathogen Candida albicans.
    Noble SM; Johnson AD
    Eukaryot Cell; 2005 Feb; 4(2):298-309. PubMed ID: 15701792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequence variations and protein expression levels of the two immune evasion proteins Gpm1 and Pra1 influence virulence of clinical Candida albicans isolates.
    Luo S; Hipler UC; Münzberg C; Skerka C; Zipfel PF
    PLoS One; 2015; 10(2):e0113192. PubMed ID: 25692293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromatin-mediated Candida albicans virulence.
    Lopes da Rosa J; Kaufman PD
    Biochim Biophys Acta; 2013; 1819(3-4):349-55. PubMed ID: 24459737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COS-l, a putative two-component histidine kinase of Candida albicans, is an in vivo virulence factor.
    Selitrennikoff CP; Alex L; Miller TK; Clemons KV; Simon MI; Stevens DA
    Med Mycol; 2001 Feb; 39(1):69-74. PubMed ID: 11270409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of calcineurin in stress resistance, morphogenesis, and virulence of a Candida albicans wild-type strain.
    Bader T; Schröppel K; Bentink S; Agabian N; Köhler G; Morschhäuser J
    Infect Immun; 2006 Jul; 74(7):4366-9. PubMed ID: 16790813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydrolytic enzymes as virulence factors of Candida albicans.
    Schaller M; Borelli C; Korting HC; Hube B
    Mycoses; 2005 Nov; 48(6):365-77. PubMed ID: 16262871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zinc Cluster Transcription Factors Alter Virulence in Candida albicans.
    Issi L; Farrer RA; Pastor K; Landry B; Delorey T; Bell GW; Thompson DA; Cuomo CA; Rao RP
    Genetics; 2017 Feb; 205(2):559-576. PubMed ID: 27932543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virulence attributes and genetic variability of oral Candida albicans and Candida tropicalis isolates.
    da Costa KR; Ferreira JC; Lavrador MA; Baruffi MD; Candido RC
    Mycoses; 2012 May; 55(3):e97-e105. PubMed ID: 22035510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dimorphism and virulence in Candida albicans.
    Mitchell AP
    Curr Opin Microbiol; 1998 Dec; 1(6):687-92. PubMed ID: 10066539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.